The study aimed to determine the changes in the shoulder pain and muscle strength in patients with diabetes-induced adhesive capsulitis (DIAC) when the different dose of Radial Extracorporeal Shock Wave Therapies (rESWT) applied.
This double-blind randomized clinical trial conducted at Okan University Research Hospital (Istanbul) with patients referred from multiple centers. Participants were≥ 45years (mean 53.49±5.81 years), had T2D for≥ 3 years (mean duration 9.92±5.70 years), had DIAC, had HbA1c≤ 9.0% (mean 7.38±0.76%); were being treated with inadequately basal insulin (20.5%) and oral antidiabetic drugs (79.5%) were enrolled. The rESWT was applied with Enraf Nonius Endoplus device with a 25mm applicator, at 8Hz, and with 2000 beats. The participants were randomly assigned to three groups as follows: high dose rESWT (hrESWT, n=13), moderate dose rESWT (mrESWT, n=13) or placebo rESWT group (prESWT, n=13). The primary outcomes were Visual Analog Scale (VAS) for pain and dynamometer evaluations for shoulder muscle strength for over the 4th and 6th week of the trial.
Without the group differences (p˃0.05) pain decreased in 4th and 6th week in all three treatment groups (p<0.001). Increased strength of shoulder flexor, extensor and rotator muscles were observed in both groups receiving active rESWT(p˂0.05). Strength of abductor's muscles did not change in all three groups (p˃0.05). There was no increase in the strength of the evaluated muscles of the prESWT group (p˃0.05).
Different doses of rESWT were effective in improving muscle strength in the diabetes-induced adhesive capsulitis. In pain reduction, rESWT was effective without being different from placebo application.